Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Cephalexin Market Price & Analysis > Featured News - Cephalexin > Zhejiang Dongya Pharmaceutical will achieve operating income of 881 million yuan in 2020, and analysis of income from main business products
— Share —

Zhejiang Dongya Pharmaceutical will achieve operating income of 881 million yuan in 2020, and analysis of income from main business products

healthoo 2021-04-30
On April 30, Zhejiang East Asia Pharmaceutical Co., Ltd. announced its 2020 annual results.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.